Neuroprotective effects of thiamine against LPS-induced neuroinflammation, synaptic dysfunction, and memory impairment in mice
World Journal of Biology and Biotechnology · 01.06.2026 · 5-9
DOI: 10.33865/wjb.11.2.1602 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Biology and Biotechnology, online erschienen am 01.06.2026. Verfasst von Irfan Safdar Durrani und 2 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The important characteristics of Alzheimer's disease (AD) include dysfunction of neuronal synapses and impairment of cognition. Since the condition can be progressive and incurable, identifying potential neuroprotective compounds to prevent it is crucial. The study aimed at assessing the advantages associated with the use of thiamine (vitamin B1) in the modulation of microglia and astrocyte activation after lipopolysaccharide (LPS). We measured activation levels of Iba-1 (ionized calcium binding adaptor molecule 1) and GFAP (glial fibrillary acidic protein) in relation to synaptic dysfunction associated with cognitive impairment in adult albino mice. We also evaluated the presence of presynptic markers (Synaptophysin) and postsynaptic markers. Mice were randomly assigned to three groups (five mice per group): control, Lipopolysaccharide (LPS)-treated, and LPS in combination with thiamine. LPS was given intraperitoneally at a dose of 250 g/kg over an extended period of 16+ days. At the same time, mice were administered a dose of thiamine at the rate of 500 μg/kg every alternate day for 10 days, i.e., a total of five doses. Findings showed that short- and long-term memory performance was impaired by LPS administration, as evidenced by significant deficits in short- and long-term memory functions, as observed in both the Morris Water Maze and the Y-Maze tests, as indicated by mean escape latency and probe test results. Thiamine-treated mice, on the other hand, had better behaviour and memory, as demonstrated by their ability to perform on the MWM and Y-Maze tests. The results of the Western blot analysis showed that glial cell stimulation by LPS, as reflected by high levels of Iba-1 and GFAP, significantly increased (p= 0.01) along with neuroinflammatory indicators, such as NF-κB. Interestingly, thiamine supplementation reversed glial cell activation and strongly suppressed NF-κB activity (p=0.05), thereby decreasing neuroinflammation in adult mouse brains. These results suggest that LPS is a neurotoxic compound, which leads to glial activation, neuroinflammation, and memory loss. Thiamine, on the other hand, suppresses glial over activity and synaptic and memory impairments, thereby conferring neuroprotective effects in the mouse model. In conclusion, this study shows that thiamine can be used to treat neurodegenerative diseases and thus has strong therapeutic potential.
Zitieren
APA
Durrani, I. S., Ahmad, D., & Jan, A. (2026). Neuroprotective effects of thiamine against LPS-induced neuroinflammation, synaptic dysfunction, and memory impairment in mice. World Journal of Biology and Biotechnology, 5-9. https://doi.org/10.33865/wjb.11.2.1602
Vancouver
Durrani IS, Ahmad D, Jan A. Neuroprotective effects of thiamine against LPS-induced neuroinflammation, synaptic dysfunction, and memory impairment in mice. World Journal of Biology and Biotechnology. 2026:5-9. doi:10.33865/wjb.11.2.1602
BibTeX
@article{Durrani2026,
author = {Durrani, Irfan Safdar and Ahmad, Dawood and Jan, Asad},
title = {Neuroprotective effects of thiamine against LPS-induced neuroinflammation, synaptic dysfunction, and memory impairment in mice},
journal = {World Journal of Biology and Biotechnology},
year = {2026},
pages = {5--9},
doi = {10.33865/wjb.11.2.1602}
}
EUVIMED